International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical MedicineAntimicrobial resistance (AMR) is increasingly challenging modern medicine and raising a pressing question: are we approaching a post-antibiotic era? This webinar examines the current situation in Switzerland and internationally, focusing on what happens when no effective antibiotic is available for a patient.
We will explore how often such situations occur, which pathogens are most concerning, and which patient populations are particularly at risk (especially critically ill patients in intensive care units; ICUs), as well as vulnerable groups in more general clinical settings. The discussion will address multidrug-resistant organisms, treatment limitations, clinical outcomes, and the real-world consequences for patient safety, hospital workflows, and healthcare systems.
Speaker: Professor Dr Silvio Daniel Brugger, FESCMID
More information: https://ifapp.org/wp-content/uploads/2026/05/Webinar-IFAPP-26-May-2026.pdf
